Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

China flag China · Delayed Price · Currency is CNY
20.29
+0.39 (1.96%)
Mar 10, 2026, 2:04 PM CST
14.18%
Market Cap 3.53B
Revenue (ttm) 124.91M
Net Income (ttm) -34.30M
Shares Out 177.52M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,622,970
Average Volume 2,556,285
Open 19.93
Previous Close 19.90
Day's Range 19.93 - 20.45
52-Week Range 14.88 - 29.49
Beta 0.54
RSI 45.36
Earnings Date Apr 24, 2026

About Shanghai ZJ Bio-Tech

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 275
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688317
Full Company Profile

Financial Performance

In 2025, Shanghai ZJ Bio-Tech's revenue was 124.91 million, a decrease of -30.08% compared to the previous year's 178.65 million. Losses were -34.30 million, -73.09% less than in 2024.

Financial Statements

News

There is no news available yet.